Drug
Capravirine clinical trials
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2000
How studies write it
Studies that test it under each name
Name
- Capravirine
- 7
Studies by the year they started
6 studies that test it; most in 2000 (4)
| Year | Studies |
|---|---|
| 2000 | 4 |
| 2002 | 1 |
| 2003 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 2
Pfizer (2) · Agouron Pharmaceuticals (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · National Cancer Institute (NCI) (1) · Lexigen Pharmaceuticals (1)
Often tested with
Tested in the same studies.
Lopinavir-ritonavir drug combination (1) · Nelfinavir (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses capravirine is read from its arms, and is right about nine times in ten.
Testing it · 7
- Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing RegimenCompletedPhase 2PfizerNCT00051844Written as Capravirine
- Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV DrugsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00005673Written as Capravirine
- Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral RegimensCompletedPhase 2PfizerNCT00052117Written as capravirine
- Capravirine to Treat Children With HIV InfectionCompletedPhase 1National Cancer Institute (NCI)NCT00006519Written as Capravirine
- Phase I Trial of S-1153 in Patients With HIV InfectionCompletedPhase 1Lexigen PharmaceuticalsNCT00002214Written as Capravirine
- Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination TherapyCompletedPhase 2Agouron PharmaceuticalsNCT00004985Written as Capravirine
- A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV TreatmentsCompletedPhase 2Agouron PharmaceuticalsNCT00006211Written as Capravirine
Codes
What other systems call capravirine · ClinicalTrials.gg INT004374
- MeSH (NLM) C433874capravirineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) VHC779598XCAPRAVIRINEConfirmed FDA, NLM, Wikidata
- Wikidata Q5036216capravirineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81612CapravirineOne source FDA
- DrugBank DB08502One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C433874 | capravirine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | VHC779598X | CAPRAVIRINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5036216 | capravirine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81612 | Capravirine | One source FDA |
| DrugBank | DB08502 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.